Search research articles
Contact Us
Filters
Showing results (301-310 of 483) with videos related to
Page
of 49
Sort By:
Journal of Cancer Research and Clinical Oncology
|
July 21, 2022
Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol
Florian Huemer, Stefan Hecht, Bernhard Scharinger, et al.
Future Oncology (London, England)
|
March 20, 2026
AGMT mCRC Registry Third-Line and Beyond: a multicentric real-world platform with integrated imaging and biosample database for later-line metastatic colorectal cancer
Florian Huemer, Gudrun Piringer, Wolfgang Eisterer, et al.
British Journal of Cancer
|
September 28, 2019
Ixazomib-Thalidomide-Dexamethasone for induction therapy followed by Ixazomib maintenance treatment in patients with relapsed/refractory multiple myeloma
Heinz Ludwig, Wolfram Poenisch, Stefan Knop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 11, 2011
Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial
Georg Pfeiler, Robert Königsberg, Christian Fesl, et al.
Haematologica
|
January 13, 2022
First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab <i>versus</i> chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial
Carol Moreno, Richard Greil, Fatih Demirkan, et al.
Annals of Hematology
|
May 21, 2021
Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL: analysis from the iLLUMINATE study
Richard Greil, Alessandra Tedeschi, Carol Moreno, et al.
Function (Oxford, England)
|
October 3, 2023
Inactivation of TRPM7 Kinase Targets AKT Signaling and Cyclooxygenase-2 Expression in Human CML Cells
Birgit Hoeger, Wiebke Nadolni, Sarah Hampe, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 26, 2018
Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group
Thomas Melchardt, Teresa Magnes, Clemens Hufnagl, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 24, 2021
Vinorelbine as substitute for vincristine in patients with diffuse large B cell lymphoma and vincristine-induced neuropathy
Stefan Hatzl, Florian Posch, Arwin Rezai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 10, 2013
AVEREL: a randomized phase III Trial evaluating bevacizumab in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive locally recurrent/metastatic breast cancer
Luca Gianni, Gilles H Romieu, Michail Lichinitser, et al.
Page
of 49
Search research articles
Search
Showing results (301-310 of 483) with videos related to
Sort By:
Page
of 49
Journal of Cancer Research and Clinical Oncology
|
July 21, 2022
Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol
Florian Huemer, Stefan Hecht, Bernhard Scharinger, et al.
Future Oncology (London, England)
|
March 20, 2026
AGMT mCRC Registry Third-Line and Beyond: a multicentric real-world platform with integrated imaging and biosample database for later-line metastatic colorectal cancer
Florian Huemer, Gudrun Piringer, Wolfgang Eisterer, et al.
British Journal of Cancer
|
September 28, 2019
Ixazomib-Thalidomide-Dexamethasone for induction therapy followed by Ixazomib maintenance treatment in patients with relapsed/refractory multiple myeloma
Heinz Ludwig, Wolfram Poenisch, Stefan Knop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 11, 2011
Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial
Georg Pfeiler, Robert Königsberg, Christian Fesl, et al.
Haematologica
|
January 13, 2022
First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab <i>versus</i> chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial
Carol Moreno, Richard Greil, Fatih Demirkan, et al.
Annals of Hematology
|
May 21, 2021
Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL: analysis from the iLLUMINATE study
Richard Greil, Alessandra Tedeschi, Carol Moreno, et al.
Function (Oxford, England)
|
October 3, 2023
Inactivation of TRPM7 Kinase Targets AKT Signaling and Cyclooxygenase-2 Expression in Human CML Cells
Birgit Hoeger, Wiebke Nadolni, Sarah Hampe, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 26, 2018
Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group
Thomas Melchardt, Teresa Magnes, Clemens Hufnagl, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 24, 2021
Vinorelbine as substitute for vincristine in patients with diffuse large B cell lymphoma and vincristine-induced neuropathy
Stefan Hatzl, Florian Posch, Arwin Rezai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 10, 2013
AVEREL: a randomized phase III Trial evaluating bevacizumab in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive locally recurrent/metastatic breast cancer
Luca Gianni, Gilles H Romieu, Michail Lichinitser, et al.
Page
of 49